Sanara MedTech
SMTI
47 hedge funds and large institutions have $26.7M invested in Sanara MedTech in 2023 Q2 according to their latest regulatory filings, with 19 funds opening new positions, 12 increasing their positions, 8 reducing their positions, and 7 closing their positions.
171% more first-time investments, than exits
New positions opened: 19 | Existing positions closed: 7
50% more repeat investments, than reductions
Existing positions increased: 12 | Existing positions reduced: 8
40% more capital invested
Capital invested by funds: $19.1M → $26.7M (+$7.66M)
34% more funds holding
Funds holding: 35 → 47 (+12)
2.44% more ownership
Funds ownership: 5.52% → 7.96% (+2.4%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$6.7M |
| 2 |
State Street
Boston,
Massachusetts
|
+$1.69M |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$1.6M |
| 4 |
Northern Trust
Chicago,
Illinois
|
+$1.05M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$974K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$1.58M |
| 2 |
EI
EAM Investors
Solana Beach,
California
|
-$1.57M |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$1.04M |
| 4 |
Jane Street
New York
|
-$726K |
| 5 |
HF
HRT Financial
New York
|
-$453K |
SMTI Hedge Fund Activity: Q2 2023 in Review
47 of the 6,370 institutional investors tracked by Wall St. Rank reported a position in Sanara MedTech (SMTI) for Q2 2023, worth a combined $26.7M — up 40% from $19.1M a quarter earlier.
Buyers outnumbered sellers: 19 funds opened new SMTI positions and 7 closed out — a net gain of 12 holders — while 12 added to existing stakes and 8 trimmed.
The largest buyer was BlackRock, adding an estimated $6.7M. The largest seller was Millennium Management, exiting entirely with an estimated $1.58M sold.
- 47 institutional investors held Sanara MedTech (SMTI) as of Q2 2023, up from 35 in Q1 2023.
- Funds reported $26.7M of Sanara MedTech stock for Q2 2023, up 40% quarter-over-quarter.
- 19 funds opened new Sanara MedTech positions in Q2 2023 and 7 closed out, a net change of +12 holders.
- The largest Sanara MedTech buyer in Q2 2023 was BlackRock, an estimated $6.7M added.
- The largest Sanara MedTech seller in Q2 2023 was Millennium Management, an estimated $1.58M sold.
Based on aggregated 13F filings for Q2 2023.